Last reviewed · How we verify

Baracross Tablet — Competitive Intelligence Brief

Baracross Tablet (Baracross Tablet) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Herbal combination product. Area: Gastrointestinal / Digestive Health.

marketed Herbal combination product Gastrointestinal / Digestive Health Small molecule Live · refreshed every 30 min

Target snapshot

Baracross Tablet (Baracross Tablet) — Daewoong Pharmaceutical Co. LTD.. Baracross is a herbal combination tablet that works through multiple plant-derived compounds to support metabolic and digestive function.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Baracross Tablet TARGET Baracross Tablet Daewoong Pharmaceutical Co. LTD. marketed Herbal combination product
STW 5-II STW 5-II Universitaire Ziekenhuizen KU Leuven marketed Herbal combination product
STW5 (Iberogast, BAY98-7411) STW5 (Iberogast, BAY98-7411) Bayer phase 3 Herbal combination product

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Herbal combination product class)

  1. Bayer · 1 drug in this class
  2. Daewoong Pharmaceutical Co. LTD. · 1 drug in this class
  3. Universitaire Ziekenhuizen KU Leuven · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Baracross Tablet — Competitive Intelligence Brief. https://druglandscape.com/ci/baracross-tablet. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: